Literature DB >> 8317491

Genetic discrimination and the public entities and public accommodations Titles of the Americans with Disabilities Act.

J S Alper1, M R Natowicz.   

Abstract

The introduction of newly developed medical genetic diagnostic tests has been accompanied by social problems involving privacy issues and genetic discrimination. Previous studies of genetic discrimination have focused on the areas of employment and insurance. In this paper, we provide six hypothetical illustrative cases of genetic discrimination involving access to public entities and to private entities considered to be public accommodations. We argue that many of these forms of genetic discrimination that arise in both the public and private sectors should be prohibited by Titles II and III, respectively, of the Americans with Disabilities Act of 1990.

Keywords:  Americans with Disabilities Act 1990; Genetics and Reproduction; Legal Approach

Mesh:

Year:  1993        PMID: 8317491      PMCID: PMC1682244     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Reply to Hook and Lowden: the definition and implications of genetic discrimination.

Authors:  Paul R Billings; Joseph S Alper; Jon Beckwith; Carol I Barash; Marvin R Natowicz
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

2.  Eugenics and genetic discrimination.

Authors:  N A Holtzman; M A Rothstein
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  The advent of DNA databanks: implications for information privacy.

Authors:  A de Gorgey
Journal:  Am J Law Med       Date:  1990

4.  Genetic discrimination: the use of genetically based diagnostic and prognostic tests by employers and insurers.

Authors:  L Gostin
Journal:  Am J Law Med       Date:  1991

Review 5.  Confidentiality of genetic information in the workplace.

Authors:  L B Andrews; A S Jaeger
Journal:  Am J Law Med       Date:  1991

6.  Sickle-cell trait as a risk factor for sudden death in physical training.

Authors:  J A Kark; D M Posey; H R Schumacher; C J Ruehle
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

7.  Hexosaminidase A deficiency in adults.

Authors:  R Navon; Z Argov; A Frisch
Journal:  Am J Med Genet       Date:  1986-05

Review 8.  Diagnosis of genetic disorders at the DNA level.

Authors:  S E Antonarakis
Journal:  N Engl J Med       Date:  1989-01-19       Impact factor: 91.245

9.  Additional polymorphisms at marker loci D9S5 and D9S15 generate extended haplotypes in linkage disequilibrium with Friedreich ataxia.

Authors:  R Fujita; A Hanauer; G Sirugo; R Heilig; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Legal aspects of genetic information.

Authors:  L B Andrews
Journal:  Yale J Biol Med       Date:  1991 Jan-Feb
View more
  3 in total

1.  Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors:  Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

2.  Anticipating unfair uses of genetic information.

Authors:  W Allen; H Ostrer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

3.  Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors.

Authors: 
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.